U.S. Uterine Fibroids Market to reach USD 39,993.2 million by 2022
Uterine Fibroid Market Report | USA Industry Outlook, Analysis and Forecast 2017-2022
(EMAILWIRE.COM, February 05, 2018 ) The United States Uterine Fibroids Market is expected to reach USD 39,993.2 million by the end of the forecasted period and is expected to grow at a CAGR of 3.24%.
Uterine Fibroids are the abnormal growth that gets developed inside or on the wall of a woman’s uterus. These are also known as leiomyoma or myomas. These are noncancerous growths that cause symptoms such as heavy bleeding between or during the menstrual cycle, pain in pelvis or lower back, increased menstrual cramping, swelling enlargement of the abdomen. Increasing prevalence due to heredity and rising number of treatments to cure this disease has fueled the growth of this market.
Browse details of our research report on United States Uterine Fibroids Market @ https://www.researchcosmos.com/reports/uterine-fibroid-market-report-usa-industry-outlook-analysis-and-forecast-2017-2022/1542768428
U.S. Uterine Fibroid Market has been segmented on the basis of type which comprises of Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others. On the basis of diagnosis the market is segmented into Medical Resonance Imaging (MRI) scanners, Computed tomography (CT), Ultrasounds and others. On the basis of treatment the market is segmented into Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy.
Key Findings:
• The U.S. Uterine Fibroid market and is expected to reach USD 39,993.2 million by 2022.
• By Type, Intramural Fibroids holds the largest market share of U.S. uterine fibroid market and is expected to reach USD 14,972.5 million by 2022.
• By Treatment, hysterectomy holds the largest market share of U.S. uterine fibroid market and is expected to reach USD 8,042.3 million by 2022.
Key Players
Some of the key players in this market are: AstraZeneca (England), Cook Medical Inc. (US), Boston Scientific Corporation (US), GE Healthcare (U.K.), AbbVie Inc. (U.S.), Hologic (U.S.), and others.
Avail Sample Market Brochure of the report for more information to evaluate report usefulness, Get a Copy @ https://www.researchcosmos.com/request/1542768428
Study Objectives:
• To provide insights about factors, influencing and affecting the market growth.
• To provide historically and forecast revenue of the market segments and sub-segments with respect to regional markets and their countries.
• To provide historical and forecast revenue of the market segments based on types, diagnosis, and treatment.
• To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market.
Target Audience
• Uterine Fibroid Devices and Drug Manufacturers
• Uterine Fibroid Devices and Drug Suppliers
• Private Research Laboratories
• Research and Development (R&D) Companies
• Market Research and Consulting Service Providers
• Medical Research Laboratories
Got some questions, Inquire @ https://www.researchcosmos.com/inquire/1542768428
About Research Cosmos:
Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.
Contact Us:
Dani Rodriguez
Sales Manager
Research Cosmos
www.researchcosmos.com
dani@researchcosmos.com
# +1 888 709 8757
Uterine Fibroids are the abnormal growth that gets developed inside or on the wall of a woman’s uterus. These are also known as leiomyoma or myomas. These are noncancerous growths that cause symptoms such as heavy bleeding between or during the menstrual cycle, pain in pelvis or lower back, increased menstrual cramping, swelling enlargement of the abdomen. Increasing prevalence due to heredity and rising number of treatments to cure this disease has fueled the growth of this market.
Browse details of our research report on United States Uterine Fibroids Market @ https://www.researchcosmos.com/reports/uterine-fibroid-market-report-usa-industry-outlook-analysis-and-forecast-2017-2022/1542768428
U.S. Uterine Fibroid Market has been segmented on the basis of type which comprises of Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others. On the basis of diagnosis the market is segmented into Medical Resonance Imaging (MRI) scanners, Computed tomography (CT), Ultrasounds and others. On the basis of treatment the market is segmented into Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy.
Key Findings:
• The U.S. Uterine Fibroid market and is expected to reach USD 39,993.2 million by 2022.
• By Type, Intramural Fibroids holds the largest market share of U.S. uterine fibroid market and is expected to reach USD 14,972.5 million by 2022.
• By Treatment, hysterectomy holds the largest market share of U.S. uterine fibroid market and is expected to reach USD 8,042.3 million by 2022.
Key Players
Some of the key players in this market are: AstraZeneca (England), Cook Medical Inc. (US), Boston Scientific Corporation (US), GE Healthcare (U.K.), AbbVie Inc. (U.S.), Hologic (U.S.), and others.
Avail Sample Market Brochure of the report for more information to evaluate report usefulness, Get a Copy @ https://www.researchcosmos.com/request/1542768428
Study Objectives:
• To provide insights about factors, influencing and affecting the market growth.
• To provide historically and forecast revenue of the market segments and sub-segments with respect to regional markets and their countries.
• To provide historical and forecast revenue of the market segments based on types, diagnosis, and treatment.
• To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market.
Target Audience
• Uterine Fibroid Devices and Drug Manufacturers
• Uterine Fibroid Devices and Drug Suppliers
• Private Research Laboratories
• Research and Development (R&D) Companies
• Market Research and Consulting Service Providers
• Medical Research Laboratories
Got some questions, Inquire @ https://www.researchcosmos.com/inquire/1542768428
About Research Cosmos:
Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.
Contact Us:
Dani Rodriguez
Sales Manager
Research Cosmos
www.researchcosmos.com
dani@researchcosmos.com
# +1 888 709 8757
Contact Information:
Research Cosmos
Dani
Tel: +1 888 709 8757
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Research Cosmos
Dani
Tel: +1 888 709 8757
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results